Pentavalent Vaccine Market Synopsis:
Pentavalent Vaccine Market Size Was Valued at USD 2.69 Billion in 2023, and is Projected to Reach USD 3.63 Billion by 2032, Growing at a CAGR of 3.4% From 2024-2032.
The Pentavalent Vaccine is a combination vaccine that protects against five different infectious diseases: DTaP, Hepatitis B, and Hib. It is meant for use in infants and young children to afford them protection from these diseases with a single shot making the tool a key element in decreasing child mortality.
The Pentavalent Vaccine market is growing mainly owing to the increasing global awareness regarding immunization or vaccination and government-led projects targeting the global promotion of immunization. It was considered essential to prevent five serious diseases that are specific threats to infant and children. Coverage of multiple diseases in its portfolio decreases the number of injections hence increasing vaccination uptake among parents and care givers. The consumption of pentavalent vaccines is preferred mostly in the developing countries where there are continued health enhancement and immunization activities.
The pentavalent vaccine market for global usage will also progress practically as a result of following factors. Some of them are the continued spread of vaccination to developing nations through agencies like GAVI, the Vaccine Alliance and WHO. They have a critical role of enhancing the provision of vaccines in areas which are still underdeveloped. Also, some countries integrate pentavalent vaccines into the programs of immunization of the population; their use is encouraged by state and international programs to prevent infectious diseases.
The raise of the vaccination coverage as one of the major global priorities in the fight against vaccine-preventable diseases contributes to the market growth as well. But cold chain management, cost structure, and some doubts concerning vaccination in some countries may act as a risk on the market growth. At the same time, the possibility of increasing the overall level of vaccinations still remains a serious prospect for the market’s participants: healthcare organizations, producers of vaccines, non-governmental organizations involved in the field of international health.
Pentavalent Vaccine Market Trend Analysis:
Rising Vaccine Awareness and Accessibility
-
The three most significant developmental patterns that impact the pentavalent vaccine market involve increased awareness regarding the effectiveness of children’s immunization. Local authorities, global health institutions and Non Govermental Organizations (INGOs) have been engaged in advocacy for vaccination that ensures availability and utilization of vaccines among the populace, especially those from hard to reach areas. Through health promotion campaigns, accompanied by combating vaccine costs, the access to immunizations or increased immunization rates has been achieved in all the regions mentioned.
- There are educational crusades, there have also been developments in the facilities of the health systems, especially in the countryside. This consists of having easier availability of vaccination centres and increased immunisation services offered by government. Due to these reasons increased distribution of the pentavalent vaccine around the globe has been enhanced meaning that children in the developing nations can now readily access vaccines. It is helping to fuel the market’s further development; every year the number of immunized children is growing and thus the incidence of severe diseases is decreasing.
Expansion in Emerging Markets
-
A higher potential for growth in the pentavalent vaccine market is shown by the emerging markets. The majority of children still resides in developing nations of Asia, Africa and Latin America, and these governments have begun to target immunization in their development agenda. Such agencies as GAVI and the WHO are availing funds and technical assistance to carry out the immunization initiatives to enhance health care thus reduce on preventable diseases such as those containing pentavalent vaccine.
- The increased production and distribution of the vaccine and in the emerging markets are also a good chance for the companies working on the pentavalent vaccine segment. Domestic producers in these areas are upping production to make up for the demand, while global vaccine makers are venturing out by partnering with governments and distributors. This expansion presents the perfect success factor for commercial ventures by enabling them to access high potential sectors that can also greatly improve global health standards.
Pentavalent Vaccine Market Segment Analysis:
Pentavalent Vaccine Market is Segmented on the basis of Type of Vaccine, Disease Coverage, Distribution Channel, End User, and Region.
By Type of Vaccine, Injectable Pentavalent Vaccine segment is expected to dominate the market during the forecast period
-
The pentavalent vaccine comes in two forms: injectable and oral. The pentavalent vaccines in the injectable form are the most widely prevalent and offer outstanding prospects of safeguard for the five chief diseases. These vaccines are normally given by injections at ages between birth and five years, depending on some recommended schedules. This is the reason why it is in many nations preferred to the freeze-dried form as the entry dose due to efficacy and ease of delivering it through healthcare networks.
- On the other hand, oral pentavalent vaccines are however rare, however, research and development, as well as their deployment is underway in some parts of world. The advantage for vaccines delivered orally is that this can be a more convenient method when compared with injections if for example there are limited health facilities, or if injection is difficult. The oral form can be more easily disseminated, and certain studies indicate that they may be less costly, and more feasible for use in large scale immunization campaigns which makes them a possible possibility concerning widespread use in the future.
By End User, Hospitals segment expected to held the largest share
-
Pentavalent vaccines are taken to different end users such as hospitals, clinic, government health care centers and vaccination drives. Such vaccines are largely administrated through hospital and clinics, and through proper vaccination schedules children are given these vaccines by healthcare professionals. These settings embrace administered environment whereby vaccine can be given with adequate safety and efficiency.
- Health centers are also important since they are run by governments and in low income areas vaccines are given at little or no cost. Such centers may supplement with other international health care agencies in order to expand the sphere of immunization services. Campaigns are conducted on mass base with cooperation of national and international health sectors to provide protection in areas with low rates of immunization. These campaigns are as well a favourable approach for guaranteeing wide coverage and utilization of pentavalent vaccines.
Pentavalent Vaccine Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America has the highest contribution to this market and it is further driven by improved health care facilities, extremely high vaccine coverage rates and improved governmental financial support for vaccination programs. The United States of America and Canada have elaborate immunization schedules that include the pentavalent vaccine in an immunization schedule for children below the age of one year as part of strategies to eliminate vaccine preventable diseases. These countries also spend a large amount of money in funding research and distribution of vaccine and making sure that pentavalent vaccines are within the easy reach of the children.
- The market share of North America has benefitted from a tripartite synergy between government health offices, private practices and drug makers. Availability of education on public health issues and the increased confidence on vaccines also play a very big part in contributing to high percentage of vaccinated people in the region. As seen, so long as north America doubles its investment in aspects such as the development of new vaccine technology and healthcare infrastructure it will remain a strong contender in the global market for pentavalent vaccines.
Active Key Players in the Pentavalent Vaccine Market:
- GlaxoSmithKline (GSK) - (United Kingdom)
- Sanofi Pasteur - (France)
- Merck & Co., Inc. - (United States)
- Pfizer Inc. - (United States)
- Serum Institute of India Pvt. Ltd. - (India)
- Bharat Biotech - (India)
- Johnson & Johnson - (United States)
- Cadila Healthcare - (India)
- Biological E. Ltd. - (India)
- Novartis International AG - (Switzerland)
- MedImmune, LLC (AstraZeneca) - (United States)
- China National Pharmaceutical Group Corporation (Sinopharm) - (China),
- Other Active Players
|
Global Pentavalent Vaccine Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 2.69 Billion |
|
Forecast Period 2024-32 CAGR: |
3.4% |
Market Size in 2032: |
USD 3.63 Billion |
|
Segments Covered: |
By Type of vaccine |
|
|
|
By Disease Coverage |
|
||
|
By End User |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Pentavalent Vaccine Market by Product Type
4.1 Pentavalent Vaccine Market Snapshot and Growth Engine
4.2 Pentavalent Vaccine Market Overview
4.3 Gel-based Pepper Sprays
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Gel-based Pepper Sprays: Geographic Segmentation Analysis
4.4 Foam-based Pepper Sprays
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Foam-based Pepper Sprays: Geographic Segmentation Analysis
4.5 Liquid-based Pepper Sprays
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Liquid-based Pepper Sprays: Geographic Segmentation Analysis
Chapter 5: Pentavalent Vaccine Market by Application
5.1 Pentavalent Vaccine Market Snapshot and Growth Engine
5.2 Pentavalent Vaccine Market Overview
5.3 Self-defense
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Self-defense: Geographic Segmentation Analysis
5.4 Law Enforcement
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Law Enforcement: Geographic Segmentation Analysis
5.5 Military
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Military: Geographic Segmentation Analysis
5.6 Sports and Outdoor Activities
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Sports and Outdoor Activities: Geographic Segmentation Analysis
Chapter 6: Pentavalent Vaccine Market by End-User
6.1 Pentavalent Vaccine Market Snapshot and Growth Engine
6.2 Pentavalent Vaccine Market Overview
6.3 Individual Consumers
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Individual Consumers: Geographic Segmentation Analysis
6.4 Government and Law Enforcement Agencies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Government and Law Enforcement Agencies: Geographic Segmentation Analysis
6.5 Security Agencies
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Security Agencies: Geographic Segmentation Analysis
Chapter 7: Pentavalent Vaccine Market by Distribution Channel
7.1 Pentavalent Vaccine Market Snapshot and Growth Engine
7.2 Pentavalent Vaccine Market Overview
7.3 Online Retail
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Online Retail: Geographic Segmentation Analysis
7.4 Offline Retail
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Offline Retail: Geographic Segmentation Analysis
7.5 Specialty Stores
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Specialty Stores: Geographic Segmentation Analysis
7.6 Supers/Hypers
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Supers/Hypers: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Pentavalent Vaccine Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 GLAXOSMITHKLINE (GSK) - (UNITED KINGDOM)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 SANOFI PASTEUR - (FRANCE)
8.4 MERCK & CO. INC. - (UNITED STATES)
8.5 PFIZER INC. - (UNITED STATES)
8.6 SERUM INSTITUTE OF INDIA PVT. LTD. - (INDIA)
8.7 BHARAT BIOTECH - (INDIA)
JOHNSON & JOHNSON - (UNITED STATES)
8.8 CADILA HEALTHCARE - (INDIA)
8.9 BIOLOGICAL E. LTD. - (INDIA)
8.10 NOVARTIS INTERNATIONAL AG - (SWITZERLAND)
8.11 MEDIMMUNE LLC (ASTRAZENECA) - (UNITED STATES)
8.12 CHINA NATIONAL PHARMACEUTICAL GROUP CORPORATION (SINOPHARM) - (CHINA)
8.13 OTHER ACTIVE PLAYERS
Chapter 9: Global Pentavalent Vaccine Market By Region
9.1 Overview
9.2. North America Pentavalent Vaccine Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Product Type
9.2.4.1 Gel-based Pepper Sprays
9.2.4.2 Foam-based Pepper Sprays
9.2.4.3 Liquid-based Pepper Sprays
9.2.5 Historic and Forecasted Market Size By Application
9.2.5.1 Self-defense
9.2.5.2 Law Enforcement
9.2.5.3 Military
9.2.5.4 Sports and Outdoor Activities
9.2.6 Historic and Forecasted Market Size By End-User
9.2.6.1 Individual Consumers
9.2.6.2 Government and Law Enforcement Agencies
9.2.6.3 Security Agencies
9.2.7 Historic and Forecasted Market Size By Distribution Channel
9.2.7.1 Online Retail
9.2.7.2 Offline Retail
9.2.7.3 Specialty Stores
9.2.7.4 Supers/Hypers
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Pentavalent Vaccine Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Product Type
9.3.4.1 Gel-based Pepper Sprays
9.3.4.2 Foam-based Pepper Sprays
9.3.4.3 Liquid-based Pepper Sprays
9.3.5 Historic and Forecasted Market Size By Application
9.3.5.1 Self-defense
9.3.5.2 Law Enforcement
9.3.5.3 Military
9.3.5.4 Sports and Outdoor Activities
9.3.6 Historic and Forecasted Market Size By End-User
9.3.6.1 Individual Consumers
9.3.6.2 Government and Law Enforcement Agencies
9.3.6.3 Security Agencies
9.3.7 Historic and Forecasted Market Size By Distribution Channel
9.3.7.1 Online Retail
9.3.7.2 Offline Retail
9.3.7.3 Specialty Stores
9.3.7.4 Supers/Hypers
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Pentavalent Vaccine Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Product Type
9.4.4.1 Gel-based Pepper Sprays
9.4.4.2 Foam-based Pepper Sprays
9.4.4.3 Liquid-based Pepper Sprays
9.4.5 Historic and Forecasted Market Size By Application
9.4.5.1 Self-defense
9.4.5.2 Law Enforcement
9.4.5.3 Military
9.4.5.4 Sports and Outdoor Activities
9.4.6 Historic and Forecasted Market Size By End-User
9.4.6.1 Individual Consumers
9.4.6.2 Government and Law Enforcement Agencies
9.4.6.3 Security Agencies
9.4.7 Historic and Forecasted Market Size By Distribution Channel
9.4.7.1 Online Retail
9.4.7.2 Offline Retail
9.4.7.3 Specialty Stores
9.4.7.4 Supers/Hypers
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Pentavalent Vaccine Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Product Type
9.5.4.1 Gel-based Pepper Sprays
9.5.4.2 Foam-based Pepper Sprays
9.5.4.3 Liquid-based Pepper Sprays
9.5.5 Historic and Forecasted Market Size By Application
9.5.5.1 Self-defense
9.5.5.2 Law Enforcement
9.5.5.3 Military
9.5.5.4 Sports and Outdoor Activities
9.5.6 Historic and Forecasted Market Size By End-User
9.5.6.1 Individual Consumers
9.5.6.2 Government and Law Enforcement Agencies
9.5.6.3 Security Agencies
9.5.7 Historic and Forecasted Market Size By Distribution Channel
9.5.7.1 Online Retail
9.5.7.2 Offline Retail
9.5.7.3 Specialty Stores
9.5.7.4 Supers/Hypers
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Pentavalent Vaccine Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Product Type
9.6.4.1 Gel-based Pepper Sprays
9.6.4.2 Foam-based Pepper Sprays
9.6.4.3 Liquid-based Pepper Sprays
9.6.5 Historic and Forecasted Market Size By Application
9.6.5.1 Self-defense
9.6.5.2 Law Enforcement
9.6.5.3 Military
9.6.5.4 Sports and Outdoor Activities
9.6.6 Historic and Forecasted Market Size By End-User
9.6.6.1 Individual Consumers
9.6.6.2 Government and Law Enforcement Agencies
9.6.6.3 Security Agencies
9.6.7 Historic and Forecasted Market Size By Distribution Channel
9.6.7.1 Online Retail
9.6.7.2 Offline Retail
9.6.7.3 Specialty Stores
9.6.7.4 Supers/Hypers
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Pentavalent Vaccine Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Product Type
9.7.4.1 Gel-based Pepper Sprays
9.7.4.2 Foam-based Pepper Sprays
9.7.4.3 Liquid-based Pepper Sprays
9.7.5 Historic and Forecasted Market Size By Application
9.7.5.1 Self-defense
9.7.5.2 Law Enforcement
9.7.5.3 Military
9.7.5.4 Sports and Outdoor Activities
9.7.6 Historic and Forecasted Market Size By End-User
9.7.6.1 Individual Consumers
9.7.6.2 Government and Law Enforcement Agencies
9.7.6.3 Security Agencies
9.7.7 Historic and Forecasted Market Size By Distribution Channel
9.7.7.1 Online Retail
9.7.7.2 Offline Retail
9.7.7.3 Specialty Stores
9.7.7.4 Supers/Hypers
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Global Pentavalent Vaccine Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 2.69 Billion |
|
Forecast Period 2024-32 CAGR: |
3.4% |
Market Size in 2032: |
USD 3.63 Billion |
|
Segments Covered: |
By Type of vaccine |
|
|
|
By Disease Coverage |
|
||
|
By End User |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
